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CASE REPORTExtrahepatic portosystemic shunt after liver
transplantation. Percutaneous embolization for
hepatic encephalopathy
M. Ennea,*, E. Balbia, L.F. Pacheco-Moreiraa, A. Cerqueiraa, H.S. Martinb,
R.P.D. Andre´a, J.L. Pereiraa, J.M. da S.G. MartinhoaaLiver Transplant Unit, Bonsucesso General Hospital, and bDepartment of Radiology, Barra d’Or Hospital,
Rio de Janeiro, BrazilIntroduction
Portal-systemic encephalopathy (PSE) is caused by
substances originating in the intestine that directly
enter the general circulation without passing
through the liver, as in extrahepatic portosystemic
shunt (EHPS). This shunt is usually a sequel of
cirrhosis and severe portal hypertension.1 It is
seldom observed in neurological complications
without portal hypertension and chronic liver
disease.2–4
The aetiology of portosystemic shunt may
involve other rare causes, such as congenital
shunts,2,3,5 iatrogenic shunts (after abdominal
operation or liver biopsy),5,6 trauma and idiopathic
shunts.2,7 The literature includes only a few cases
of portosystemic shunt not associated with portal
hypertension,2,7,8 mostly in Western countries.
The occlusion of shunts is sometimes indicated
for PSE.6–9 Recently, good results have been
reported for the percutaneous approach using
interventional radiology in cases of EHPS occlusion,
via the liver or the inferior vena cava.5
We report a case of a 54-year-old woman
presenting with one episode of PSE 27 months
after undergoing liver transplantation, without
recurrence of cirrhosis or portal hypertension. The
portosystemic shunt was diagnosed by abdominal
colour-Doppler and magnetic resonance image
angiography (MRIA). Spectroscopic cranial MR1477-6804/$ - see front matter q 2004 The Royal College of Radiolo
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with percutaneous vascular embolization.
In summary, PSE may occur many years after
liver transplantation, even in the absence of portal
hypertension and liver fibrosis, and may be due to
old shunts not eliminated during transplant surgery.
Percutaneous embolization can achieve good
results. We report a case where the portosystemic
shunt occurred between the superior mesenteric
vein and the left ovarian vein. To the best of our
knowledge, there is only one previous report of
percutaneous embolization of portosystemic shunts
after liver transplantation.10Case report
A 54-year-old woman underwent liver transplan-
tation at our unit for decompensated cirrhosis due
to chronic alcoholism. The early postoperative
course was complicated by intra-abdominal bleed-
ing at day 5, prompted by abdominal drain removal
and requiring further surgery.
Pretransplantation abdominal imaging included
colour Doppler sonography and MRIA, and showed a
collateral vessel draining from the superior mesen-
teric vein into the right ovarian vein (Fig. 1). During
the transplantation no attempt was made to
interrupt this large vessel. Routine intraoperative
colour Doppler evaluation was made after the graft
reperfusion, and indicated a 24 cm/s mean rate
velocity of portal vein hepatopetal flow.
The first postoperative months were uneventful,
except for an episode of cytomegalovirus (CMV)
pneumonitis treated with 21 days of intravenous
ganciclovir (DHPG), with resolution. The womanClinical Radiology Extra (2004) 59, 116–119gists. Published by Elsevier Ltd. All rights reserved.
Figure 1 Magnetic resonance imaging angiography,
showing a collateral vessel (open arrow) draining from
the superior mesenteric vein(short arrow) into the right
ovarian vein (white arrow).
Figure 2 Spectroscopic cranial magnetic resonance
confirmed portosystemic encephalopathy with high signal
in globus pallidus T1-weighted images.
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colour Doppler sonography. Serum chemistry was
repeatedly normal, sonography showed no abnor-
mal vessels, and a 56 cm/s mean rate flow in the
main portal vein was noted.
At 24 months, colour Doppler sonography showed
an abnormal vessel (2.0 cm in diameter) running to
the superior mesenteric vein, on the right side of
the abdomen, raising the suspicion of a portal vein
stenosis at the level of the anastomosis and
extrahepatic portal hypertension. MRIA clearly
demonstrated that this vessel originated from the
superior mesenteric vein and communicated with
the right ovarian vein, as in the pretransplantation
image. Histology of the liver demonstrated a
normal portal triad, without fibrosis. Upper tract
endoscopy showed no varices.
Percutaneous transhepatic portography was car-
ried out in an attempt to perform a balloon
dilatation of suspected portal vein stenosis. The
portography showed no stenosis and 12 mmHg
portal vein pressure, both below and above the
level of the anastomosis (without gradient press-
ure), and balloon dilatation was not attempted.The woman continued close follow-up on an
outpatient basis. Three months later she was
admitted to the hospital complaining of memory
lapses and sleeping difficulties for 1-month. The
neurological symptoms included confusion and
abnormal behaviour, progressing to coma. Labora-
tory investigations demonstrated normal chem-
istry; brain CT and lumbar puncture showed no
anomalies. Spectroscopic cranial MR confirmed PSE
with high signal in globus pallidus T1-weighted
images (Fig. 2). The woman received oral lactulose
and neomycin, and improved after 48 h.
As colour Doppler sonography demonstrated a
large varix on the superior mesenteric vein to the
right side of the abdomen, percutaneous vascular
embolization was considered suitable. The shunt
was performed percutaneously, via the right
femoral vein (Fig. 3), and two stainless coils were
successfully delivered through the right ovarian
vein into the large collateral vein (Fig. 4).
The postoperative course was uneventful, and
colour Doppler sonography revealed disappearance
of the shunt flow. The woman was discharged at day
4, and 14 months postoperatively repeated colour
Doppler sonography showed complete obstruction
of the shunt. There were no symptoms of encepha-
lopathy and no medical therapy was required.
Figure 3 Contrast medium in the enlarged right ovarian
vein (white arrow) and the collateral vessel (open arrow),
administered through the right femoral vein.
Figure 4 Two stainless coils were successfully deliv-
ered through the right ovarian vein into the large
collateral vein (white arrow).
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One of the complications of end-stage liver disease
is hepatic encephalopathy. This neurological con-
dition is almost always due to portosystemic venous
shunts, caused by portal hypertension and impaired
liver function secondary to progressive hepatic
fibrosis in cirrhotic individuals. There have also
been reports of a few cases in which “hepatic”
encephalopathy developed in non-cirrhotic patients
without portal hypertension; here the term “hepa-
hepatic” might not be appropriate. Watanabe,2 in
an extensive review of these cases of encephalo-
pathy in non-cirrhotic patients, used the distinctive
term “portal-systemic encephalopathy” rather than
“hepatic encephalopathy”. Some of these cases of
encephalopathy without liver cirrhosis have been
misdiagnosed as psychoneurological disorders.
Portosystemic shunts may be located inside or
outside the liver. The intrahepatic type occurs
between the portal and hepatic veins. This is
sometimes congenital, accompanied by anomalies
of the portal system such as Rendu-Osler-Weber
disease, or a patent venous duct between the left
branch of the portal vein and the left hepatic vein.Intrahepatic acquired shunts may be due to trauma,
biopsy or surgery. The extrahepatic portosystemic
shunts may also be congenital in the rare cases of
portal vein absence (when the superior mesenteric
vein runs to the inferior vena cava). Many extra-
hepatic shunts occur between the splenic, the left
gastric or superior mesenteric vein and the left
renal vein. In exceptional cases, the shunt passes
through ovarian or testicular veins.
In liver transplantation large extrahepatic por-
tosystemic shunts are of major significance and are
found at preoperative angiographic assessment in
up to 60% of cirrhotic patients.11 These shunts can
steal portal flow after the graft implantation, and
may account for graft hypoperfusion, poor graft
function and portal vein thrombosis. However,
sometimes the “steal” phenomenon may be present
solely after an acute rejection episode.11,12 These
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transplantation procedure.
In 1995 Sezai et al.6 described the first case of
percutaneous embolization in a cirrhotic patient.
Sekido et al.12 also described liver transplantation
in which graft hypofunction was determined by
large mesenteric varices; the shunt was, however,
ligated by conventional surgery.
We report a case where the portosystemic shunt
occurred between the superior mesenteric vein and
the left ovarian vein. To the best of our knowledge,
there is only one previous report of percutaneous
embolization of portosystemic shunts after liver
transplantation.10
In summary, portosystemic encephalopathy due
to portosystemic shunt may occur many years after
liver transplantation, even in the absence of portal
hypertension and liver fibrosis. This can be due to
old shunts not eliminated during the transplant
surgery. The trigger of this complication so long
after the liver transplantation remains controver-
sial. Percutaneous embolization treatment can
achieve good results and should be considered in
these patients.References
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